loadpatents
Patent applications and USPTO patent grants for Verner; Erik J..The latest application filed is for "inhibitors of bruton's tyrosine kinase".
Patent | Date |
---|---|
Inhibitors of Bruton's Tyrosine Kinase App 20220213106 - Buggy; Joseph J. ;   et al. | 2022-07-07 |
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor App 20220098200 - Ben Haim; Cyril ;   et al. | 2022-03-31 |
Inhibitors Of Bruton's Tyrosine Kinase App 20220008424 - Honigberg; Lee ;   et al. | 2022-01-13 |
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor App 20200347064 - Ben Haim; Cyril ;   et al. | 2020-11-05 |
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors App 20200289515 - Honigberg; Lee ;   et al. | 2020-09-17 |
Inhibitors Of Bruton's Tyrosine Kinase App 20200108072 - Honigberg; Lee ;   et al. | 2020-04-09 |
Inhibitors Of Brutons Tyrosine Kinase App 20200055859 - Buggy; Joseph J. ;   et al. | 2020-02-20 |
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor App 20190367518 - Ben Haim; Cyril ;   et al. | 2019-12-05 |
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof App 20190184196 - Loury; David J. ;   et al. | 2019-06-20 |
Formulations of histone deacetylase inhibitor and uses thereof Grant 10,105,552 - Loury , et al. October 23, 2 | 2018-10-23 |
Inhibitors Of Bruton's Tyrosine Kinase App 20180085372 - HONIGBERG; LEE ;   et al. | 2018-03-29 |
Synthesis Of A Bruton?s Tyrosine Kinase Inhibitor App 20180009814 - Benhaim; Cyril ;   et al. | 2018-01-11 |
Inhibitors Of Bruton's Tyrosine Kinase App 20170362246 - Buggy; Joseph J. ;   et al. | 2017-12-21 |
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof App 20170333731 - Loury; David J. ;   et al. | 2017-11-23 |
Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors App 20170246169 - Honigberg; Lee ;   et al. | 2017-08-31 |
Inhibitors Of Bruton's Tyrosine Kinase App 20170007611 - Honigberg; Lee ;   et al. | 2017-01-12 |
Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof Grant 9,492,423 - Loury , et al. November 15, 2 | 2016-11-15 |
Formulations of histone deacetylase inhibitor and uses therof Grant 9,403,032 - Loury , et al. August 2, 2 | 2016-08-02 |
Hydroxamates as therapeutic agents Grant 9,186,347 - Verner , et al. November 17, 2 | 2015-11-17 |
Novel Hydroxamates As Therapeutic Agents App 20150320718 - VERNER; Erik J. ;   et al. | 2015-11-12 |
Inhibitors of bruton's tyrosine kinase Grant 9,139,591 - Honigberg , et al. September 22, 2 | 2015-09-22 |
Inhibitors of Bruton'S tyrosine kinase Grant 9,079,908 - Honigberg , et al. July 14, 2 | 2015-07-14 |
Formulations Of Histone Deacetylase Inhibitor And Uses Therof App 20150164854 - LOURY; David J. ;   et al. | 2015-06-18 |
Inhibitors of bruton's tyrosine kinase Grant 8,940,750 - Honigberg , et al. January 27, 2 | 2015-01-27 |
Formulations Of Histone Deacetylase Inhibitor In Combination With Bendamustine And Uses Thereof App 20140341989 - Loury; David J. ;   et al. | 2014-11-20 |
Novel Hydroxamates As Therapeutic Agents App 20140301976 - VERNER; Erik J. ;   et al. | 2014-10-09 |
Hydroxamates as therapeutic agents Grant 8,779,171 - Verner , et al. July 15, 2 | 2014-07-15 |
Formulations Of Histone Deacetylase Inhibitor And Uses Therof App 20140057862 - LOURY; David J. ;   et al. | 2014-02-27 |
Formulations of histone deacetylase inhibitor and uses thereof Grant 8,603,521 - Loury , et al. December 10, 2 | 2013-12-10 |
Novel Hydroxamates As Therapeutic Agents App 20130142758 - VERNER; Erik J. ;   et al. | 2013-06-06 |
Hydroxamates as therapeutic agents Grant 8,389,570 - Verner , et al. March 5, 2 | 2013-03-05 |
Inhibitors Of Bruton's Tyrosine Kinase App 20130035334 - HONIGBERG; Lee ;   et al. | 2013-02-07 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120329130 - Honigberg; Lee ;   et al. | 2012-12-27 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120296089 - Honigberg; Lee ;   et al. | 2012-11-22 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120277225 - Honigberg; Lee ;   et al. | 2012-11-01 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120277255 - Honigberg; Lee ;   et al. | 2012-11-01 |
Inhibitors Of Il2-inducible T-cell Kinase App 20120202264 - Honigberg; Lee ;   et al. | 2012-08-09 |
Inhibitors of BMX non-receptor tyrosine kinase App 20120184013 - Honigberg; Lee ;   et al. | 2012-07-19 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120184567 - Honigberg; Lee ;   et al. | 2012-07-19 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120178753 - Honigberg; Lee ;   et al. | 2012-07-12 |
Inhibitors Of B Lymphocyte Kinase App 20120165328 - Honigberg; Lee ;   et al. | 2012-06-28 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120101113 - Honigberg; Lee ;   et al. | 2012-04-26 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120101114 - Honigberg; Lee ;   et al. | 2012-04-26 |
Novel Hydroxamates As Therapeutic Agents App 20120064032 - Verner; Erik J. ;   et al. | 2012-03-15 |
Inhibitors Of Bruton's Tyrosine Kinase App 20120065201 - Honigberg; Lee ;   et al. | 2012-03-15 |
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof App 20110311624 - LOURY; David J. ;   et al. | 2011-12-22 |
Hydroxamates as therapeutic agents Grant 8,026,371 - Verner , et al. September 27, 2 | 2011-09-27 |
Novel Hydroxamates As Therapeutic Agents App 20110021528 - Verner; Erik J. ;   et al. | 2011-01-27 |
Hydroxamates as therapeutic agents Grant 7,834,054 - Verner , et al. November 16, 2 | 2010-11-16 |
Inhibitors Of Bruton's Tyrosine Kinase App 20100254905 - Honigberg; Lee ;   et al. | 2010-10-07 |
Novel Hydroxamates As Therapeutic Agents App 20090220454 - Verner; Erik J. ;   et al. | 2009-09-03 |
Hydroxamates as therapeutic agents Grant 7,517,988 - Verner , et al. April 14, 2 | 2009-04-14 |
Hydroxamates as therapeutic agents Grant 7,482,466 - Verner , et al. January 27, 2 | 2009-01-27 |
Novel Hydroxamates As Therapeutic Agents App 20080255221 - Verner; Erik J. ;   et al. | 2008-10-16 |
Novel Hydroxamates As Therapeutic Agents App 20080255214 - Verner; Erik J. ;   et al. | 2008-10-16 |
Hydroxamates as therapeutic agents Grant 7,420,089 - Verner , et al. September 2, 2 | 2008-09-02 |
Novel Hydroxamates As Therapeutic Agents App 20080004331 - Verner; Erik J. ;   et al. | 2008-01-03 |
Novel Hydroxamates As Therapeutic Agents App 20070293540 - Verner; Erik J. ;   et al. | 2007-12-20 |
Mesylate salt of 5-(2-dimethylaminoethoxy)-1H-indole-2-carboxylic acid [3-(4-hydroxycarbamoylphenyl)prop-2-ynyl]amide App 20070105939 - Verner; Erik J. | 2007-05-10 |
Novel hydroxamates as therapeutic agents App 20050187261 - Verner, Erik J. ;   et al. | 2005-08-25 |
(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors Grant 6,867,200 - Allen , et al. March 15, 2 | 2005-03-15 |
Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin Grant 5,594,021 - Chan , et al. January 14, 1 | 1997-01-14 |
Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin Grant 5,591,761 - Chan , et al. * January 7, 1 | 1997-01-07 |
Sulfonamides and derivatives thereof that modulate the activity of endothelin Grant 5,571,821 - Chan , et al. November 5, 1 | 1996-11-05 |
SEC | 0001664488 | Verner Erik J. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.